Commerzbank Aktiengesellschaft’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,690	Closed	-$145K	–	1039
2016 Q4	$145K	Sell	35,690 -2,306	-6%	-$9.57K	﹤0.01%	934
2016 Q3	$142K	Sell	37,996 -4,603	-11%	-$16.8K	﹤0.01%	874
2016 Q2	$145K	Buy	42,599 +453	+1%	+$2.08K	﹤0.01%	951
2016 Q1	$224K	Sell	42,146 -23,240	-36%	-$186K	﹤0.01%	944
2015 Q4	$804K	Sell	65,386 -15,750	-19%	-$210K	0.01%	725
2015 Q3	$1.19M	Buy	81,136 +11,667	+17%	+$202K	0.01%	544
2015 Q2	$1.35M	Buy	69,469 +4,856	+8%	+$93.7K	0.01%	729
2015 Q1	$1.17M	Buy	+64,613	New	+$1.45M	0.01%	753

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commerzbank Aktiengesellschaft's CTIC Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q1 2017, closing a stake of 35,690 shares — an estimated $145K sold.

Commerzbank Aktiengesellschaft first reported a position in CTIC in Q1 2015 and held it in 8 quarters. The position peaked at $1.35M in Q2 2015. 47 funds tracked by Wall St. Rank hold CTIC as of Q1 2017.

Commerzbank Aktiengesellschaft reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q1 2017 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 35,690 CTI BioPharma Corp. (DE) Common Stock shares in Q1 2017, an estimated $145K.
Commerzbank Aktiengesellschaft first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2015 and held it in 8 quarters.
Commerzbank Aktiengesellschaft's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.35M in Q2 2015.
47 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.